MRI Devices has received FDA clearance for its Biopsy Breast Coil, a radio-frequency array design for use with eight-channel MR systems. Integrated within the coil is a system for breast immobilization, localization of suspicious lesions, and guidance of
MRI Devices has received FDA clearance for its Biopsy Breast Coil, a radio-frequency array design for use with eight-channel MR systems. Integrated within the coil is a system for breast immobilization, localization of suspicious lesions, and guidance of MR-compatible interventional instruments such as localization wires and biopsy needles.
Computed Tomography Study Assesses Model for Predicting Recurrence of Non-Small Cell Lung Cancer
January 31st 2025A predictive model for non-small cell lung cancer (NSCLC) recurrence, based on clinical parameters and CT findings, demonstrated an 85.2 percent AUC and 83.3 percent sensitivity rate, according to external validation testing in a new study.